Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Carcinogenesis|March 20, 2016
Innate immune signaling through differential RIPK1 expression promote tumor progression in head and neck squamous cell carcinomaKevin D McCormick, Arundhati Ghosh, Sumita Trivedi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2016
CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck CancerRaghvendra M Srivastava, Sumita Trivedi, Fernando Concha-Benavente, et al.
Scientific Reports|May 14, 2024
Transcriptomic analysis-guided assessment of precision-cut tumor slices (PCTS) as an ex-vivo tool in cancer researchSumita Trivedi, Caitlin Tilsed, Maria Liousia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2016
Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer PatientsSumita Trivedi, Raghvendra M Srivastava, Fernando Concha-Benavente, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2016
Enhanced Cytotoxic CD8 T Cell Priming Using Dendritic Cell-Expressing Human Papillomavirus-16 E6/E7-p16INK4 Fusion Protein with Sequenced Anti-Programmed Death-1Tatiana M Garcia-Bates, Eun Kim, Fernando Concha-Benavente, et al.
The Laryngoscope|October 27, 2020
Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult PopulationAndrew Tkaczuk, Sumita Trivedi, Mayur D Mody, et al.
Cancer Research|December 18, 2015
Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck CancerFernando Concha-Benavente, Raghvendra M Srivastava, Sumita Trivedi, et al.
Cancer Epidemiology|March 25, 2016
Characterization of human papillomavirus antibodies in individuals with head and neck cancerKrystle A Lang Kuhs, Michael Pawlita, Sandra P Gibson, et al.
Cancer Immunology Research|May 15, 2015
STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC PatientsRaghvendra M Srivastava, Sumita Trivedi, Fernando Concha-Benavente, et al.
Pageof 3